Radavelli-Bagatini, Simone http://orcid.org/0000-0001-6821-5217
Anokye, Reindolf
Bondonno, Nicola P.
Sim, Marc
Bondonno, Catherine P.
Stanley, Mandy J.
Harms, Craig
Woodman, Richard
Magliano, Dianna J.
Shaw, Jonathan E.
Daly, Robin M.
Hodgson, Jonathan M.
Lewis, Joshua R.
Blekkenhorst, Lauren C.
Funding for this research was provided by:
National Health and Medical Research Council (NHMRC) of Australia Emerging Leadership Investigator Grant (1172987)
National Heart Foundation of Australia Post-Doctoral Research Fellowship (102498)
National Heart Foundation of Australia Future Leader Fellowship (102817)
National Health and Medical Research Council of Australia Senior Research Fellowship (1116973)
NHMRC Investigator Grant (1173952)
Article History
Received: 11 November 2020
Accepted: 3 March 2021
First Online: 29 March 2021
Declarations
:
: DJM and JES report grants from Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, Eli Lilly Australia, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Roche Diagnostics Australia, Sanofi Aventis and Sanofi-synthelabo, during the conduct of the study. RMD received a Primary Growth Partnership grant via the Ministry of Primary Industries in New Zealand with Fonterra Co-operative Group Ltd, outside the submitted work. All other authors have no potential conflicts of interest to report. JMH reports grants from FruitWest, grants from Department of Agriculture and Food WA, outside the submitted work.
: The study was approved by The Human Research Ethics Committees of the International Diabetes Institute, and the Alfred Hospital (Melbourne, Australia).